BioSpace News Archive

FDA

Mylan Announces U.S. FDA Approval Of First Generic For Copaxone 40 Mg/Ml 3-Times-A-Week And May Be Eligible For 180-Day Exclusivity

October 4, 2017
·
9 min read
Biotech Beach

Five-Year Clinical Research Study By USC Roski Eye Institute First To Compare Surgical Systems In Diabetic Retinal Detachment Repair

October 4, 2017
·
5 min read
Business

Siamab And Boehringer Ingelheim Announce Strategic Cancer Immunology Discovery Collaboration To Develop Antibody Therapeutics Targeting Multiple Solid Tumors

October 4, 2017
·
3 min read
Business

Synthego And Thermo Fisher Scientific Align To Manufacture And Distribute Synthetic Guide RNA Products For CRISPR Genome Engineering

October 4, 2017
·
2 min read
Business

InGeneron Brings Aboard a New CEO

October 4, 2017
·
2 min read
Drug Development

Theratechnologies Announces 48-Week Efficacy And Safety Results For Ibalizumab Presented At IDWeek 2017

October 4, 2017
·
6 min read
Business

Bio-Tissue Announces Strategic Agreement With Bright Optical To Promote Its Regenerative Healing Technology In Canada

October 4, 2017
·
3 min read
Policy

Avita Medical Release: U.S. FDA Approves New Continued Access Protocol For The ReCell Device For Treatment Of Burn Injuries

October 4, 2017
·
6 min read
Business

Gilead Announces New License Agreement With The Medicines Patent Pool For Access To Bictegravir

October 4, 2017
·
4 min read
Drug Development

Gilead Presents Results From Phase III Study Evaluating Patients Who Switched To Investigational Fixed-Dose Combination Of Bictegravir, Emtricitabine And Tenofovir Alafenamide From Boosted Protease Inhibitor-Based Regimens

October 4, 2017
·
5 min read